Pacific Biosciences of California, Inc. PACB

Updated: 9 Aug 2026

NASDAQ | Biotech | Genomic sequencing solutions

No signal published yet

We already track Pacific Biosciences of California and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Pacific Biosciences of California free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Genomic sequencing solutions
We're already tracking Pacific Biosciences of California, Inc. — here are the latest events we've registered

Recent News

  • On August 5, 2026, Pacific Biosciences reported second-quarter 2026 revenue of $39.0 million and lowered its full-year guidance. The company also announced a leadership transition with Mark Van Oene appointed as President and CEO, succeeding Christian Henry. In addition, PacBio approved a restructuring plan to reduce operating expenses alongside performance enhancements for its Vega sequencing system.

What Firelda Watch includes for Pacific Biosciences of California, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Pacific Biosciences of California, Inc. will be delivered in the same format.

Want to follow Pacific Biosciences of California, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Pacific Biosciences of California free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Pacific Biosciences of California, Inc. PACB
Pacific Biosciences of California — follow and we'll monitor it
Follow Pacific Biosciences of California free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.